Literature DB >> 25619707

Gamma glutamyl transferase and oxidative stress in obstructive sleep apnea: a study in 1744 patients.

A Sánchez-Armengol1, P Villalobos-López, C Caballero-Eraso, C Carmona-Bernal, M Asensio-Cruz, F Barbé, F Capote.   

Abstract

OBJECTIVE: We analyze a large population of patients to determine whether gamma glutamyl transferase (GGT) levels are increased in sleep apnea-hypopnea syndrome (OSA) and whether these levels are related to clinical characteristics or polygraphic indexes.
METHODS: A cross-sectional study in a population of 1744 patients referred for OSA suspicion was conducted. The following variables were determined: glucose, cholesterol, triglycerides, aspartate aminotransferase (GOT), alanine aminotransferase (GPT), GGT, body mass index, waist-hip ratio (WHR), and overnight sleep study.
RESULTS: The 483 patients with GGT ≥40 IU/l were younger and more obese, and had a pattern of more centrally distributed fat than the 1261 with GGT <40 IU/l. Patients with high levels of GGT also consumed more alcohol, had a poorer biochemical profile, and had more respiratory and oximetric alterations during sleep. GGT levels were significantly correlated with AHI, DI, and CT90. In the binary regression test, WHR, glucose, cholesterol, triglycerides, and grams of alcohol consumed per day predicted GGT levels ≥40 IU/l, while none of the polygraphic variables had predictive value.
CONCLUSIONS: High GGT levels were associated with the severity of OSA. However, this relationship seems to be due to the coexistence of other associated factors, mainly central obesity, rather than to the respiratory disorders found in this disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25619707     DOI: 10.1007/s11325-014-1115-5

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  24 in total

1.  The association of oxidative stress with central obesity in obstructive sleep apnea.

Authors:  Sang Don Lee; Gawon Ju; Ji-Ae Choi; Jeong-Whun Kim; In-Young Yoon
Journal:  Sleep Breath       Date:  2011-05-26       Impact factor: 2.816

2.  Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.

Authors:  Elfriede Ruttmann; Larry J Brant; Hans Concin; Günter Diem; Kilian Rapp; Hanno Ulmer
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

3.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

4.  Respiratory polygraphy with actigraphy in the diagnosis of sleep apnea-hypopnea syndrome.

Authors:  Emilio García-Díaz; Esther Quintana-Gallego; Aránzazu Ruiz; Carmen Carmona-Bernal; Ángeles Sánchez-Armengol; Georgina Botebol-Benhamou; Francisco Capote
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

5.  Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.

Authors:  Douglas S Lee; Jane C Evans; Sander J Robins; Peter W Wilson; Irene Albano; Caroline S Fox; Thomas J Wang; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

6.  Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study.

Authors:  Tatjana Stojakovic; Hubert Scharnagl; Michael Trauner; Burkert Pieske; Britta Wellnitz; Ursula Seelhorst; Dieter Schilling; Bernhard R Winkelmann; Bernhard O Boehm; Winfried März
Journal:  Atherosclerosis       Date:  2009-07-23       Impact factor: 5.162

7.  Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study.

Authors:  Duk-Hee Lee; Myron D Gross; David R Jacobs
Journal:  Clin Chem       Date:  2004-01-15       Impact factor: 8.327

8.  Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.

Authors:  Konstantinos Christou; Konstantinos Kostikas; Chaido Pastaka; Kalliopi Tanou; Irene Antoniadou; Konstantinos I Gourgoulianis
Journal:  Sleep Med       Date:  2008-02-20       Impact factor: 3.492

9.  Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population.

Authors:  C Meisinger; A Döring; A Schneider; H Löwel
Journal:  Atherosclerosis       Date:  2006-02-17       Impact factor: 5.162

Review 10.  [Obesity, insulin resistance and increase in adipokines levels: importance of the diet and physical activity].

Authors:  E Rodríguez-Rodríguez; J M Perea; A M López-Sobaler; R M Ortega
Journal:  Nutr Hosp       Date:  2009 Jul-Aug       Impact factor: 1.057

View more
  4 in total

1.  Serum gamma glutamyl transferase in patients with sleep apnea-hypopnea.

Authors:  Tomoyuki Kawada
Journal:  Sleep Breath       Date:  2015-07-09       Impact factor: 2.816

2.  Gamma glutamyl transferase in 1744 patients with obstructive sleep apnea.

Authors:  A Sánchez-Armengol; P Villalobos-López; C Caballero-Eraso; C Carmona-Bernal; M Asensio-Cruz; F Barbé; F Capote
Journal:  Sleep Breath       Date:  2015-07-09       Impact factor: 2.816

3.  The association of sleep with metabolic pathways and metabolites: evidence from the Dietary Approaches to Stop Hypertension (DASH)-sodium feeding study.

Authors:  Vanessa L Z Gordon-Dseagu; Andriy Derkach; Qian Xiao; Ishmael Williams; Joshua Sampson; Rachael Z Stolzenberg-Solomon
Journal:  Metabolomics       Date:  2019-03-16       Impact factor: 4.290

4.  Oxidative stress does not contribute to the release of proinflammatory cytokines through activating the Nod-like receptor protein 3 inflammasome in patients with obstructive sleep apnoea.

Authors:  Tingyu Tang; Qingdong Huang; Juan Liu; Xiaoxi Zhou; Jianzong Du; Haiyan Wu; Zhijun Li
Journal:  Sleep Breath       Date:  2018-10-03       Impact factor: 2.816

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.